Quick Answer
VACCINEX, INC. reported Operating Income of -$18.73 million for fiscal year 2024.
VACCINEX, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$18.73M | +18.1% |
| 2023 | -$22.89M | -15.0% |
| 2022 | -$19.91M | +11.5% |
| 2021 | -$22.49M | +20.6% |
| 2020 | -$28.33M | +11.5% |
| 2019 | -$32.02M | -17.4% |
| 2018 | -$27.28M | -29.3% |
| 2017 | -$21.10M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$4.55M | +22.0% | +20.4% |
| June 30, 2024 | -$5.72M | +19.1% | -12.8% |
| March 31, 2024 | -$5.07M | -1.8% | +13.0% |
| September 30, 2023 | -$5.83M | -21.7% | +17.6% |
| June 30, 2023 | -$7.08M | -31.0% | -41.9% |
| March 31, 2023 | -$4.99M | -8.5% | -4.0% |
| September 30, 2022 | -$4.79M | +5.4% | +11.3% |
| June 30, 2022 | -$5.40M | +4.7% | -17.6% |
- VACCINEX, INC. showed an increase of +18.1% in Operating Income compared to the prior fiscal year.
- Over the 2017–2024 period, VACCINEX, INC.’s operating income has grown by 11.2% (from -$21.10 million to -$18.73 million).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: